Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a hair regrowth treatment, may worsen acne.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

Facial trichostasis spinulosa is a chronic condition with significant cosmetic impact, especially in young women.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Pattern mode isolation improves the reliability and predictability of Turing patterns.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib is an effective and safe treatment for alopecia areata.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Trichostatin A helps restore hair-growing ability in skin cells used for hair regeneration.

Trichoscopy helps accurately diagnose temporal triangular alopecia.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

The study found that Tourette Syndrome may be linked to certain immune system processes and synaptic signaling.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Tabby mutations in mice affect hair follicle development and help study genetic mapping and certain medical conditions.

Method accurately measures finasteride and tamsulosin in combined drug form.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib effectively treats Alopecia Areata.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.